{"id":11220,"date":"2024-07-21T19:30:20","date_gmt":"2024-07-21T19:30:20","guid":{"rendered":"https:\/\/eunewsroom.com\/dankzij-ozempic-werd-novo-nordisk-het-waardevolste-bedrijf-van-europa-kan-de-farmaceut-die-groei-wel-aan-de-volkskrant\/"},"modified":"2024-07-21T19:30:20","modified_gmt":"2024-07-21T19:30:20","slug":"dankzij-ozempic-werd-novo-nordisk-het-waardevolste-bedrijf-van-europa-kan-de-farmaceut-die-groei-wel-aan-de-volkskrant","status":"publish","type":"post","link":"https:\/\/eunewsroom.com\/nl\/dankzij-ozempic-werd-novo-nordisk-het-waardevolste-bedrijf-van-europa-kan-de-farmaceut-die-groei-wel-aan-de-volkskrant\/","title":{"rendered":"Dankzij Ozempic werd Novo Nordisk het waardevolste bedrijf van Europa. Kan de farmaceut die groei wel aan? &#8211; de Volkskrant"},"content":{"rendered":"<p> <br \/>\n<br \/><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMilwFodHRwczovL3d3dy52b2xrc2tyYW50Lm5sL2J1aXRlbmxhbmQvZGFua3ppai1vemVtcGljLXdlcmQtbm92by1ub3JkaXNrLWhldC13YWFyZGV2b2xzdGUtYmVkcmlqZi12YW4tZXVyb3BhLWthbi1kZS1mYXJtYWNldXQtZGllLWdyb2VpLXdlbC1hYW5-YjZjYmE1YWYv0gEA?oc=5\" target=\"_blank\" rel=\"noopener\">Dankzij Ozempic werd Novo Nordisk het waardevolste bedrijf van Europa. Kan de farmaceut die groei wel aan?<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">de Volkskrant<\/font><br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.volkskrant.nl\/buitenland\/dankzij-ozempic-werd-novo-nordisk-het-waardevolste-bedrijf-van-europa-kan-de-farmaceut-die-groei-wel-aan~b6cba5af\/\">Bron <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dankzij Ozempic werd Novo Nordisk het waardevolste bedrijf van Europa. Kan de farmaceut die groei wel aan?&nbsp;&nbsp;de Volkskrant Bron<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1132,1147],"tags":[],"class_list":{"0":"post-11220","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-business-nl","7":"category-business-fr"},"_links":{"self":[{"href":"https:\/\/eunewsroom.com\/nl\/wp-json\/wp\/v2\/posts\/11220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eunewsroom.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eunewsroom.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eunewsroom.com\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eunewsroom.com\/nl\/wp-json\/wp\/v2\/comments?post=11220"}],"version-history":[{"count":0,"href":"https:\/\/eunewsroom.com\/nl\/wp-json\/wp\/v2\/posts\/11220\/revisions"}],"wp:attachment":[{"href":"https:\/\/eunewsroom.com\/nl\/wp-json\/wp\/v2\/media?parent=11220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eunewsroom.com\/nl\/wp-json\/wp\/v2\/categories?post=11220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eunewsroom.com\/nl\/wp-json\/wp\/v2\/tags?post=11220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}